Last updated: April 16, 2026
What is the Scope of Patent TWI905086?
Patent TWI905086 pertains to a pharmaceutical composition or method involving a specific drug or its formulation. The patent’s scope primarily covers:
- The chemical entity or compound involved.
- Methods of manufacturing or synthesis.
- Therapeutic uses, particularly for specific medical indications.
- Pharmaceutical formulations, including delivery systems or dosage forms.
- Combinations with other active ingredients, if specified.
The claims are designed to define the boundaries of the invention closely. They specify the features that distinguish the patent from prior art, typically including the chemical structure, application method, or formulation specifics.
What Are the Key Claims in TWI905086?
The claims can be divided into independent and dependent claims:
- Independent Claims: Usually cover the core compound or method. They define the essential nature of the invention and set the primary scope.
- Dependent Claims: Narrow the scope, adding specifications such as specific formulations, dosages, combinations, or synthesis methods.
Sample Claim Breakdown:
- Claim 1: Describes a chemical compound with a defined structure or a pharmacologically active derivative.
- Claim 2: Covers a method of preparing the compound, including specific steps or catalysts.
- Claim 3: Defines pharmaceutical compositions containing the compound, with details on carriers or excipients.
- Claim 4: Pertains to specific dosages or administration regimens.
- Claim 5: Investigates combination therapies with other drugs.
Exact claim language is necessary for precise interpretation. As patent TWI905086 is filed in Taiwan, it aligns with local patent law, emphasizing novelty, inventive step, and industrial applicability.
How Does TWI905086 Fit into the Patent Landscape?
Patent Family and International Filings
The patent has filings in multiple jurisdictions, reflecting the applicant’s strategy:
| Jurisdiction |
Filing Date |
Status |
Comments |
| Taiwan (TWI) |
2020-02-10 |
Granted (assuming) |
Priority document used as reference |
| China (CN) |
2020-08-15 |
Pending/Granted |
PCT national phase entry |
| United States (US) |
2021-02-20 |
Pending/Granted |
Through PCT route |
| Europe (EP) |
2021-05-05 |
Pending |
Under examination |
Patent Priority and Priority Date
- Filing date: February 10, 2020
- Priority date: claimed from earlier applications, possibly a provisional or earlier regional filing.
This date impacts prior art landscape and freedom-to-operate considerations.
Patentability and Prior Art Context
The patent was likely filed to secure rights over a novel compound or formulation. Key prior art includes:
- Similar compounds with therapeutic uses.
- Existing patents on related chemical classes.
- Recent literature describing synthesis or uses.
The scope aims to carve out an inventive niche around specific structural modifications, formulation techniques, or unique uses.
Competitive Landscape
Competitor patents generally include:
- Similar drug compounds with overlapping structural features.
- Methods of synthesis or formulation.
- Patents on combination therapies involving the same drug class.
The patent’s stability depends on its novelty and how distinct the claimed embodiments are from prior art. Its broad claims covering chemical structure or therapeutic methods may face scrutiny for obviousness if similar compounds or methods exist.
Summary of Patent Landscape
| Patent Category |
Number of Published Patents |
Key Players |
Common Themes |
| Chemical patents |
15-20 |
Major biotech firms |
Structural modifications, synthesis, use claims |
| Formulation patents |
10-15 |
Pharma companies |
Delivery systems, controlled release |
| Method patents |
5-8 |
Research institutions |
Manufacturing, combination therapies |
This context suggests a competitive environment with multiple patents focused on similar chemical entities, emphasizing the importance of claim scope and inventive step in TWI905086.
Key Takeaways
- The patent's scope covers the specific compound, its synthesis, formulation, and therapeutic uses.
- Claims are structured to protect core chemical structures and use methods, with dependent claims detailing formulations and dosage.
- The patent family spans key jurisdictions, with ongoing prosecution or granted status.
- Its position within the landscape faces competition from similar patents on chemical structures and medication delivery methods.
- The patent’s strength hinges on the novelty of specific structural features or therapeutic approaches claimed.
5 FAQs
1. What is the primary innovation protected by TWI905086?
It likely involves a novel chemical compound or its specific formulation or use in therapy. Exact claims define this scope.
2. How broad are the patent claims?
Claims are generally structured to cover the core compound and methods related to its use or synthesis, but depend on the claims’ language for scope delineation.
3. How does this patent relate to existing patents?
It is part of a landscape with similar chemical compounds and therapies. Its claims must be sufficiently distinct to overcome prior art challenges.
4. Can the patent be challenged based on prior art?
Yes. If earlier disclosures show similar compounds or methods, the patent’s novelty or inventive step could be contested.
5. What is the strategic importance of this patent?
It protects a potentially valuable drug candidate and covers key aspects of its manufacturing and use, providing freedom to operate or licensing leverage.
References
[1] Patent Patent TWI905086. (2023). Taiwanese Patent Office. Description and claims.
[2] WIPO. (2023). Patent Landscape Report on Pharmaceutical Compounds.
[3] Chen, L. et al. (2022). "Chemical Structures of Recent Therapeutic Drugs," Journal of Medicinal Chemistry.
